Mexican Chamber of Deputies Approves New Legislation to Ban the Illicit Use of E-Cigarettes

Dec.04.2024
Mexican Chamber of Deputies Approves New Legislation to Ban the Illicit Use of E-Cigarettes
The Mexican Chamber of Deputies has passed a constitutional amendment to prohibit the illicit use of fentanyl and e-cigarette products, and will adjust the relevant legal framework to align with the new law.

According to El Mexicano, on December 3rd, the Mexican Chamber of Deputies passed a bill with 410 votes in favor, 24 against, and zero abstentions, which prohibits the illegal use of products such as fentanyl and e-cigarettes in the constitution.

 

This reform is part of a package of 20 initiatives proposed by President Andrés Manuel López Obrador. The move comes after the 2022 National Health and Nutrition Survey revealed that e-cigarette use among adolescents reached 2.6% of the reference population (approximately 500 individuals) and 1.5% of the adult population (around 300,000 individuals), contributing to negative health impacts.

 

The Federal Commission for the Protection against Sanitary Risks (COFEPRIS) reported that in 2022, around five million people aged 12 to 65 had tried vaping devices, with 975,000 using them regularly.

 

In response to these figures, the approved reform adds provisions to Articles 4 and 5 of the Political Constitution of the United Mexican States, aimed at enhancing health protection. It establishes that "to ensure the right to health protection for individuals, the law will penalize any activity related to e-cigarettes, vaping devices, and other similar electronic systems or devices, as well as the production, distribution, and sale of toxic substances, chemical precursors, the illicit use of fentanyl, and other unauthorized synthetic drugs."

 

The amendment also prohibits professions, industries, internal and external commerce, employment, or any other activity related to these substances.

 

The law specifies the prohibition of the production, distribution, and sale of toxic substances, chemical precursors, and the illicit use of unauthorized synthetic drugs such as fentanyl and methamphetamines.

 

The reform stipulates that the Congress of the Union will have 180 days to harmonize existing legal frameworks with the decree's contents, and each of Mexico's 32 states must make the required regulatory adjustments within 365 days of the reform's publication.

 

The Plenary session clarified that no additional funds would be authorized for the implementation of this decree. All costs resulting from its enactment will be covered by the existing budgets of the responsible authorities for the current fiscal year.

 

Notice

1. This article is provided exclusively for professional research purposes related to industry, technology and policy. Any reference to brands or products is made solely for the purpose of objective description and does not constitute an endorsement, recommendation, or promotion of any brand or product.

2. The use of nicotine products, including but not limited to cigarettes, e-cigarettes, and heated tobacco products, is associated with significant health risks. Users are required to comply with all relevant laws and regulations in their respective jurisdictions.

3. This article is strictly restricted from being accessed or viewed by individuals under the legal age.

Copyright

This article is either an original work by 2Firsts or a reproduction from third-party sources with the original source clearly indicated. The copyright and usage rights of this article belong to 2Firsts or the original source. Unauthorized reproduction, distribution, or any other unauthorized use of this article by any entity or individual is strictly prohibited. Violators will be held legally responsible. For copyright-related matters, please contact: info@2firsts.com

AI Assistance Disclaimer

This article may have utilized AI to enhance translation and editing efficiency. However, due to technical limitations, errors may occur. Readers are advised to refer to the sources provided for more accurate information.

This article should not be used as a basis for any investment decisions or advice, and 2Firsts assumes no direct or indirect liability for any errors in the content.